June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Genotype - phenotype analysis in a family with autosomal dominant retinitis pigmentosa and a mutation in SNRNP200.
Author Affiliations & Notes
  • Christina Gerth-Kahlert
    Dept of Ophthalmology, University of Zurich, Zurich, Switzerland
  • Amit Tiwari
    Institute of Medical Molecular Genetics, University of Zürich, Schlieren, Switzerland
  • Angela Bahr
    Institute of Medical Molecular Genetics, University of Zürich, Schlieren, Switzerland
  • James V.M. Hanson
    Dept of Ophthalmology, University of Zurich, Zurich, Switzerland
  • Wolfgang Berger
    Institute of Medical Molecular Genetics, University of Zürich, Schlieren, Switzerland
    Zurich Center for Integrative Human Physiology (ZIHP), University of Zürich, Zurich, Switzerland
  • Footnotes
    Commercial Relationships   Christina Gerth-Kahlert, None; Amit Tiwari, None; Angela Bahr, None; James Hanson, None; Wolfgang Berger, None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2767. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Christina Gerth-Kahlert, Amit Tiwari, Angela Bahr, James V.M. Hanson, Wolfgang Berger; Genotype - phenotype analysis in a family with autosomal dominant retinitis pigmentosa and a mutation in SNRNP200.. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2767.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Mutations in SNRNP200 are associated with autosomal dominant retinitis pigmentosa (RP). We performed whole exome sequencing (WES) in a patient with RP and evaluated the phenotype characteristics in the patient's family. which shows a potentially pathogenic mutation in the SNRNP200 gene.

Methods : The index patient and 3 of the affected family members received a comprehensive eye examination with a detailed retinal functional (ffERG; mfERG) and morphological (OCT; autofluorescence) assessment. Genetic testing was performed by WES in the index patient using an Illumina NextSeq 500 platform. Sequence data were compared with the reference human genome hg19. Alignment and variant calling was performed at the Base Space Onsite. Annotation of variants was done using Alamut-Batch and visualized by Alamut-Viewer. Potentially disease-associated sequence variants in retinal disease genes were then confirmed by Sanger sequencing in additional affected and one unaffected family members.

Results : All patients described nyctalopia as the first presenting symptom during childhood to young adulthood. Visual acuity ranged from 20/30 (age 35yrs) to 20/200 (age 68yrs). 2/4 patients are highly myopic. FfERG responses were non-recordable, mfERG responses were severely diminished. Retinal morphology showed typical signs of RP with severely diminished outer retinal layers on OCT. One obligate carrier does not report visual symptoms but was not yet available for testing. Genetic analysis revealed a missense variant in exon 25 of the SNRNP200 gene as the most likely disease-associated sequence variation in the index patient (c.3260C>T, p.Ser1087Leu). The same mutation was previously reported as pathogenic, is predicted to be strongly pathogenic and is also predicted to affect canonical splicing of exon 25. Subsequent segregation analysis in additional affected and unaffected family members supported this interpretation. In addition, the index patient had novel compound heterozygous variants in the MYO7A gene (p.Tyr1580Cys and p.Glu1794Lys) and previously disease-associated heterozygous variants in CRB1 (p.Arg1331His) and AIPL1 (p.Arg324Leu). These variants may act as disease modifiers.

Conclusions : An amino acid substitution in SNRNP200 appears to cause a typical RP phenotype with intra-familial variability and incomplete penetrance in the investigated family.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×